8-K - IMMUNIC, INC. (0001280776) (Filer)
Published . Updated .
Key takeaways
- 8-K - IMMUNIC filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: IMUX
- Market reaction: IMUX +1.1% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - IMMUNIC filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- IMUX Immunic
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Immunic belongs to, so it often moves with news about it.
- LLY Eli Lilly and
Eli Lilly and is a peer of Immunic in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson
Johnson & Johnson is a peer of Immunic in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie
AbbVie is a peer of Immunic in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck
Merck is a peer of Immunic in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories
Abbott Laboratories is a peer of Immunic in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IMUX | -2.13% | -7.39% | base | -7.77% | -2.38% | +0.06% | +1.13% |
| XLV | -2.96% | -2.66% | base | -2.36% | -2.53% | -0.67% | -0.41% |
| LLY | -3.15% | -0.45% | base | -3.07% | -4.46% | -0.41% | +1.01% |
| JNJ | -0.43% | -2.09% | base | -1.43% | -0.00% | +2.09% | +1.60% |
| ABBV | -1.41% | -2.06% | base | -1.94% | -1.14% | -0.54% | -0.35% |
| MRK | -2.69% | -1.28% | base | -2.02% | -2.40% | -1.09% | -1.58% |
| ABT | -9.53% | -4.57% | base | -1.75% | -4.84% | -4.37% | -4.43% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001193805-26-001432 Size: 10 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 5 Nov 2026: Immunic (IMUX) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -1.94% | final price |
| ABBV | the next day | -1.14% | final price |
| ABBV | two days later | -0.54% | final price |
| ABBV | three days later | -0.35% | final price |
| ABBV | three days earlier | -2.06% | final price |
| ABBV | five days earlier | -1.41% | final price |
| ABT | that day | -1.75% | final price |
| ABT | the next day | -4.84% | final price |
| ABT | two days later | -4.37% | final price |
| ABT | three days later | -4.43% | final price |
| ABT | three days earlier | -4.57% | final price |
| ABT | five days earlier | -9.53% | final price |
| Immunic (IMUX) | that day | -7.77% | final price |
| Immunic (IMUX) | the next day | -2.38% | final price |
| Immunic (IMUX) | two days later | +0.06% | final price |
| Immunic (IMUX) | three days later | +1.13% | final price |
| Immunic (IMUX) | three days earlier | -7.39% | final price |
| Immunic (IMUX) | five days earlier | -2.13% | final price |
| JNJ | that day | -1.43% | final price |
| JNJ | the next day | -0.00% | final price |
| JNJ | two days later | +2.09% | final price |
| JNJ | three days later | +1.60% | final price |
| JNJ | three days earlier | -2.09% | final price |
| JNJ | five days earlier | -0.43% | final price |
| LLY | that day | -3.07% | final price |
| LLY | the next day | -4.46% | final price |
| LLY | two days later | -0.41% | final price |
| LLY | three days later | +1.01% | final price |
| LLY | three days earlier | -0.45% | final price |
| LLY | five days earlier | -3.15% | final price |
| MRK | that day | -2.02% | final price |
| MRK | the next day | -2.40% | final price |
| MRK | two days later | -1.09% | final price |
| MRK | three days later | -1.58% | final price |
| MRK | three days earlier | -1.28% | final price |
| MRK | five days earlier | -2.69% | final price |
| XLV | that day | -2.36% | final price |
| XLV | the next day | -2.53% | final price |
| XLV | two days later | -0.67% | final price |
| XLV | three days later | -0.41% | final price |
| XLV | three days earlier | -2.66% | final price |
| XLV | five days earlier | -2.96% | final price |
Congressional trades in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 16 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 34 days before publication. Filed 27 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - IMMUNIC, INC. (0001280776) (Filer)”
Companies tied to this story
- IMUX Immunic
For “8-K - IMMUNIC, INC. (0001280776) (Filer),” Immunic (IMUX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IMUX
How “8-K - IMMUNIC, INC. (0001280776) (Filer)” reaches Immunic (IMUX)
On 5 Nov 2026, “8-K - IMMUNIC, INC. (0001280776) (Filer)” is the story that connects Immunic (IMUX) to this story.
Immunic (IMUX) is on the page because SEC 8-K filing -> direct issuer disclosure -> IMUX
What the saved facts support for Immunic (IMUX)
14 out of 100
“8-K - IMMUNIC, INC. (0001280776) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.